Evidence map›Paper›PMID 39916860›Full record

ArticleFrontiers in microbiology2025

Predatory bacteria can intensify lung-injury in a multidrug-resistant

Zeinab Mohsenipour, Farzaneh Kianian, Behnaz Jahanbin, Hamid Reza Abtahi, Tooba Ghazanfari, Maryam Edalatifard, Saeid Amanpour, Mikael Skurnik, Parya Arazi, Mohammad Mehdi Feizabadi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Therapeutic strategies for multi-resistantJAC-antimicrobial resistance · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zeinab MohsenipourDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Farzaneh KianianDepartment of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Behnaz JahanbinDepartment of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Hamid Reza AbtahiDepartment of Pulmonary and Critical Care, Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Tooba GhazanfariImmunoregulation Research Center, Shahed University, Tehran, Iran.
Maryam EdalatifardDepartment of Pulmonary and Critical Care, Thoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Saeid AmanpourCancer Biology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mikael SkurnikDepartment of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Parya AraziDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Mehdi FeizabadiDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Respiratory tract infection caused by antibiotic-resistant bacteria are one of the most important causes of death worldwide. Therefore, in this study, we investigated the possibility of using predatory bacteria to improve the Methods: Multidrug-resistant (MDR) Results: The most successful treatment was observed in the group treated with colistin followed by combined treatment. In the predator treatment group, the systemic spread of Discussion: This is the first report of systemic complications of using

Indexed as

Acinetobacter baumanniiantibiotic resistantBdellovibrio bacteriovoruspredatory bacteriarespiratory tract infection

Identifiers

PMID39916860
PMCPMC11798975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.